HURA · NASDAQ
TuHURA Biosciences (HURA) Stock Price & Fundamentals
TuHURA Biosciences (HURA) closed at $442.65 on Oct 9, 2026, down 0.53% from the previous close of $444.99.
Share price, past year
1Y +20.82%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $442.65 |
| Sep 30, 2026 | $448.61 |
| Aug 31, 2026 | $437.10 |
| Jul 31, 2026 | $404.13 |
| Jun 30, 2026 | $386.59 |
| May 29, 2026 | $375.10 |
| Apr 30, 2026 | $380.73 |
| Mar 31, 2026 | $345.22 |
| Feb 27, 2026 | $354.79 |
| Jan 30, 2026 | $347.99 |
| Dec 31, 2025 | $362.95 |
| Nov 28, 2025 | $374.93 |
| Oct 31, 2025 | $371.96 |
Key statistics
- Market cap
- $28.19B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.54
- Revenue (TTM)
- —
- Net income (TTM)
- −$30.62M
- Shares outstanding
- 63.7M
- Dividend yield
- —
- 52-week range
- $345.22 – $449.76
TuHURA Biosciences's market cap is $28.19B, based on a share price of $442.65 and 63.7M shares outstanding as of Jun 30, 2026.
Financials
TuHURA Biosciences reported revenue of $0.00 for fiscal 2025.
TuHURA Biosciences reported a net loss of $30.05M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | — | −$30.05M | — | −$0.63 | −$27.71M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$29.32M | — | −$2.47 | −$12.03M |
| FY2012ended Jun 30, 2012 | $0.00 | — | — | — | $0.00 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$7.54M | −$0.13 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$6.66M | −$0.15 |
| Q3 FY2024ended Mar 31, 2024 | $0.00 | −$4.84M | −$0.40 |
| Q4 FY2012ended Jun 30, 2012 | $0.00 | — | — |
| Q3 FY2012ended Mar 31, 2012 | $0.00 | — | — |
| Q4 FY2011ended Dec 31, 2011 | $0.00 | — | — |
| Q3 FY2011ended Sep 30, 2011 | $0.00 | — | — |
| Q2 FY2011ended Jun 30, 2011 | $0.00 | — | — |
Company profile
- Name
- TuHURA Biosciences, Inc./NV
- Ticker
- HURA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 10500 University Center Dr., Suite 110, Tampa, FL 33612
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001498382
Recent SEC filings
- Sep 24, 2026
- Sep 17, 2026
- Sep 16, 2026
- Sep 4, 2026
- Aug 21, 2026
- Aug 19, 2026
- Aug 14, 2026
- Aug 14, 2026
Frequently asked questions
What is TuHURA Biosciences's stock price?
TuHURA Biosciences (HURA) closed at $442.65 on Oct 9, 2026, down 0.53% from the previous close of $444.99.
What is TuHURA Biosciences's market cap?
TuHURA Biosciences's market cap is $28.19B, based on a share price of $442.65 and 63.7M shares outstanding as of Jun 30, 2026.
How much revenue does TuHURA Biosciences make?
TuHURA Biosciences reported revenue of $0.00 for fiscal 2025.
Does TuHURA Biosciences pay a dividend?
TuHURA Biosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from TuHURA Biosciences, Inc./NV's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures